v3.26.1
CONCENTRATION (Tables)
9 Months Ended
Mar. 31, 2026
Risks and Uncertainties [Abstract]  
Schedule of Operating Results

The Company's operations are just organized into one business segment based on the nature of products and services offered. Summary operating results for each of its products were as follows:

 

   Three months Ended
March 31,
   Nine months Ended
March 31,
 
   2026   2025   2026   2025 
Sales            
Anti-Aging & Immune Support  $14,010   $50,008   $184,764   $254,404 
Targeted System Support   9,655    6,140    55,286    32,809 
Herbal Insulin Support   2,478    -    18,752    - 
Total sales  $26,143   $56,148   $258,802   $287,213 
Cost of Goods Sold                    
Anti-Aging & Immune Support  $1,226   $5,858   $64,286   $22,505 
Targeted System Support   1,392    473    16,118    3,003 
Herbal Insulin Support   992    -    6,650    - 
Total cost of goods sold  $3,610   $6,331   $87,054   $25,508 
Gross Profit                    
Anti-Aging & Immune Support  $12,784   $44,150   $120,478   $231,899 
Targeted System Support   8,263    5,667    39,168    29,806 
Herbal Insulin Support   1,486    -    12,102    - 
Total gross profit  $22,533   $49,817   $171,748   $261,705 
Selling Expense                    
Anti-Aging & Immune Support  $628   $13,363   $17,600   $33,855 
Targeted System Support   3,068    892    15,206    3,594 
Herbal Insulin Support   2,190    -    25,406    - 
Total selling expense  $5,886   $14,255   $58,212   $37,449 
Schedule of Concentration in Account Payable
   For the three months ended March 31,   For the nine months ended March 31, 
   2026   2025   2026   2025 
   Amounts   Percentages   Amounts   Percentages   Amounts   Percentages   Amounts   Percentages 
Customer A  $3,406    13%  $10,560    19%  $57,000    22%  $32,980    11%
Customer B   2,613    10%   6,900    12%   55,877    22%   -    -%
Customer C   2,600    10%   6,708    12%   -    -%   -    -%
Customer D   -    -%   6,012    11%   -    -%   -    -%
Customer E   -    -%   6,000    11%   -    -%   -    -%
Customer F  $-    -%  $5,580    10%  $-    -%  $-    -%
   For the three months ended March 31,   For the nine months ended March 31, 
   2026   2025   2026   2025 
   Amounts   Percentages   Amounts   Percentages   Amounts   Percentages   Amounts   Percentages 
Supplier A  $5,211    100%  $5,138    100%  $38,920    53%  $41,668    63%
Supplier B   -    -    -    -    31,668    43%   17,019    25%
Supplier C  $-    - %  $-    - %  $-    -%  $7,940    12%